Atlas Trials

A Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Allogeneic iNKT Cell Infusion in Subjects With Advanced Pancreatic Cancer

Clinical trial NCT07055568 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07055568
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2025-09-30
Primary completion
2027-09-30
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.